BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27662440)

  • 1. The Desmopressin Test Predicts Better Than Basal Cortisol the Long-Term Surgical Outcome of Cushing's Disease.
    Vassiliadi DA; Balomenaki M; Asimakopoulou A; Botoula E; Tzanela M; Tsagarakis S
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4878-4885. PubMed ID: 27662440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease.
    Romanholi DJ; Machado MC; Pereira CC; Danilovic DS; Pereira MA; Cescato VA; Cunha Neto MB; Musolino NR; de Mendonça BB; Salgado LR
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):117-22. PubMed ID: 18182093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative follow-up of Cushing's disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparison.
    Le Marc'hadour P; Muller M; Albarel F; Coulon AL; Morange I; Martinie M; Gay E; Graillon T; Dufour H; Conte-Devolx B; Chabre O; Brue T; Castinetti F
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):216-22. PubMed ID: 25660243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent cortisol response to desmopressin predicts recurrence of Cushing's disease in patients with post-operative corticotropic insufficiency.
    Cambos S; Mohammedi K; Castinetti F; Saie C; Young J; Chanson P; Tabarin A
    Eur J Endocrinol; 2020 May; 182(5):489-498. PubMed ID: 32187576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test.
    Dall'Asta C; Barbetta L; Bonavina L; Beck-Peccoz P; Ambrosi B
    Pituitary; 2004; 7(3):183-188. PubMed ID: 16328567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing's disease.
    Castinetti F; Martinie M; Morange I; Dufour H; Sturm N; Passagia JG; Conte-Devolx B; Chabre O; Brue T
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1897-903. PubMed ID: 19276234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Cushing's disease remission after transsphenoidal surgery based on early serum cortisol dynamics.
    Costenaro F; Rodrigues TC; Rollin GA; Ferreira NP; Czepielewski MA
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):411-8. PubMed ID: 23895112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.
    Hameed N; Yedinak CG; Brzana J; Gultekin SH; Coppa ND; Dogan A; Delashaw JB; Fleseriu M
    Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
    J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.
    Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery.
    Lindsay JR; Oldfield EH; Stratakis CA; Nieman LK
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2057-64. PubMed ID: 21508126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical predictors of outcome of pituitary surgery for Cushing's disease.
    Alwani RA; de Herder WW; van Aken MO; van den Berge JH; Delwel EJ; Dallenga AH; De Jong FH; Lamberts SW; van der Lely AJ; Feelders RA
    Neuroendocrinology; 2010; 91(2):169-78. PubMed ID: 19907141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease.
    Losa M; Bianchi R; Barzaghi R; Giovanelli M; Mortini P
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3322-8. PubMed ID: 19584185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease.
    Losa M; Mortini P; Dylgjeri S; Barzaghi R; Franzin A; Mandelli C; Giovanelli M
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):61-8. PubMed ID: 11453953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery.
    Patil CG; Prevedello DM; Lad SP; Vance ML; Thorner MO; Katznelson L; Laws ER
    J Clin Endocrinol Metab; 2008 Feb; 93(2):358-62. PubMed ID: 18056770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.
    Ramm-Pettersen J; Halvorsen H; Evang JA; Rønning P; Hol PK; Bollerslev J; Berg-Johnsen J; Helseth E
    BMC Endocr Disord; 2015 Oct; 15():62. PubMed ID: 26499317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease.
    Wang F; Catalino MP; Bi WL; Dunn IF; Smith TR; Guo Y; Hordejuk D; Kaiser UB; Laws ER; Min L
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e94-e102. PubMed ID: 33108450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of the combined corticotropin-releasing hormone plus desmopressin stimulation during petrosal sinus sampling is both sensitive and specific in differentiating patients with Cushing's disease from patients with the occult ectopic adrenocorticotropin syndrome.
    Tsagarakis S; Vassiliadi D; Kaskarelis IS; Komninos J; Souvatzoglou E; Thalassinos N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2080-6. PubMed ID: 17356045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting late recurrence in surgically treated patients with Cushing's disease.
    Barbot M; Albiger N; Koutroumpi S; Ceccato F; Frigo AC; Manara R; Fassina A; Gardiman MP; Scanarini M; Mantero F; Scaroni C
    Clin Endocrinol (Oxf); 2013 Sep; 79(3):394-401. PubMed ID: 23278711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cushing's disease: the desmopressin test as a compelling predictive marker of long-term remission after transsphenoidal surgery.
    Vassiliadi DA; Tsagarakis S
    Eur J Endocrinol; 2020 Jun; 182(6):C17-C19. PubMed ID: 32234974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.